CANDRIAM S.C.A. – Alnylam Pharmaceuticals, Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$70.67M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +2.87% | 9.83K shares | 20.61M | $200.16 | 353.04K |
| Q2 2022 | share | Increase | +13.03% | 39.56K shares | 474K | $145.85 | 343.21K |
| Q1 2022 | share | Increase | +26.22% | 63.08K shares | 8.78M | $163.29 | 303.65K |
| Q4 2021 | share | Increase | +80.77% | 107.49K shares | 15.67M | $171.03 | 240.57K |
| Q3 2021 | share | Decrease | -23.88% | -41.74K shares | -4.51M | $188.81 | 133.07K |
| Q2 2021 | share | Increase | +7.54% | 12.26K shares | 9.34M | $169.52 | 174.82K |
| Q1 2021 | share | 0.00% | 0 shares | -834K | $141.19 | 162.55K | |
| Q4 2020 | share | Decrease | -3.01% | -5.04K shares | -3.27M | $129.97 | 162.55K |
| Q3 2020 | share | 0.00% | 0 shares | -422K | $145.6 | 167.6K | |
| Q2 2020 | share | Decrease | -12.13% | -23.13K shares | 3.35M | $148.11 | 167.6K |
| Q1 2020 | share | 0.00% | 0 shares | -494K | $108.85 | 190.73K | |
| Q4 2019 | share | Increase | +0.35% | 659 shares | 6.68M | $115.17 | 190.73K |
| Q3 2019 | share | Decrease | -50.21% | -191.65K shares | -12.29M | $80.42 | 190.07K |
| Q2 2019 | share | Increase | +34.08% | 97.02K shares | 970K | $72.56 | 381.72K |
| Q1 2019 | share | 0.00% | 0 shares | 5.84M | $93.45 | 284.70K | |
| Q4 2018 | share | Increase | +23.14% | 53.49K shares | 522K | $72.91 | 284.70K |
| Q3 2018 | share | Increase | +94.77% | 112.5K shares | 8.54M | $87.52 | 231.21K |
| Q2 2018 | share | Increase | +24.68% | 23.5K shares | 352K | $98.49 | 118.71K |
| Q1 2018 | share | Increase | +0.11% | 102 shares | -743K | $119.1 | 95.21K |
| Q4 2017 | share | Decrease | -20.74% | -24.89K shares | -2.01M | $127.05 | 95.10K |
| Q3 2017 | share | Increase | +42.86% | 36K shares | 7.39M | $117.49 | 120K |
| Q2 2017 | share | Increase | +25.37% | 17K shares | 3.26M | $79.76 | 84K |
| Q1 2017 | share | Increase | +11.67% | 7K shares | 1.18M | $51.25 | 67K |
| Q4 2016 | share | 0.00% | 0 shares | -1.82M | $37.44 | 60K | |
| Q3 2016 | share | Decrease | -17.81% | -13K shares | 16K | $67.78 | 60K |
| Q2 2016 | share | Increase | +19.67% | 12K shares | 243K | $55.49 | 73K |
| Q1 2016 | share | Increase | +7.02% | 4K shares | -1.55M | $62.77 | 61K |